Five years after its formation, the Clinical and Translational Science Award (CTSA) at the Univeristy of North Carolina at Chapel Hill (UNC), the North Carolina Translational and Clinical Sciences Institute (NC TraCS), has become the integrated, campus-wide home for clinical and translational research at UNC. The overall goal of this U54 Cooperative Agreement application is to combine the research strengths, resources and opportunities at UNC and new partner, RTI International (RTI), to build on the foundation established in the CTSA's last five years. NC TraCS .will work to improve human health by accelerating clinical and translational research from health science discovery to dissemination to patients and communities. NC TraCS will strive to overcome the well-documented barriers to the effective, sustained translation of research discovery along the translational research continuum by improving efficiency, training a research workforce and exporting successful, validated methods developed in NC TraCS to other CTSA institutions and the public. The proposed CTSA will specifically (1) amplify a thriving CTSA program to the point that it supports the full spectrum of clinical and translational research;(2) leverage CTSA resources and institutional strengths to create a critical, sustained focus on three strategic initiatives: (a) next-generation technologies to transform the very nature of clinical research and practice, (b) new paradigms and resources to accelerate drug development, and (c) robust comparative effectiveness research studies to provide definitive evidence of the benefits and harms of tests and treatments;and (3) train, support and incentivize the next generation of clinical and translational science researchers. These goals will be accomplished by three resources, six services, integrated and streamlined from the original 11, and the three strategic initiatives. UNC and RTI now have a unique set of research and training resources to support the full range of clinical and translational research, from basic science to clinical application to policy change. NC TraCS will leverage the opportunity of this CTSA application to garner >$60 million dollars in matching institutional support to extend our capabilities to meet the three aims. In partnership with RTI, NC TraCS will take advantage of the resources it has created and nourished during the past five years to quickly and effectively bring the fruits of research to patients across the state, as well as nationally through the CTSA Consortium.

Public Health Relevance

Researchers, clinicians and health policy experts have long lamented the well-documented lag between basic science discoveries and when those discoveries reach patients to treat them and make their lives better. The proposed UNC-RTI partnership in cooperation with the CTSA Consortium will help to ensure that patients will more quickly and effectively benefit from the results of biomedical research.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR001111-02S1
Application #
8917646
Study Section
Special Emphasis Panel (ZAI1-PTM-C (S1))
Program Officer
Wilde, David B
Project Start
2013-09-26
Project End
2018-04-30
Budget Start
2014-09-06
Budget End
2015-03-05
Support Year
2
Fiscal Year
2014
Total Cost
$113,442
Indirect Cost
$38,809
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Rohweder, Catherine L; Laping, Jane L; Diehl, Sandra J et al. (2016) Bridging Research, Practice, and Policy: The ""Evidence Academy"" Conference Model. J Public Health Manag Pract 22:200-3
Check, Devon K; Samuel, Cleo A; Rosenstein, Donald L et al. (2016) Investigation of Racial Disparities in Early Supportive Medication Use and End-of-Life Care Among Medicare Beneficiaries With Stage IV Breast Cancer. J Clin Oncol 34:2265-70
Dusetzina, Stacie B; Keating, Nancy L (2016) Mind the Gap: Why Closing the Doughnut Hole Is Insufficient for Increasing Medicare Beneficiary Access to Oral Chemotherapy. J Clin Oncol 34:375-80
Brown, Callie L; Skinner, Asheley C; Yin, H Shonna et al. (2016) Parental Perceptions of Weight During the First Year of Life. Acad Pediatr 16:558-64
Leeman, Jennifer; Blitstein, Jonathan L; Goetz, Joshua et al. (2016) Developing a Tool to Assess the Capacity of Out-of-School Time Program Providers to Implement Policy, Systems, and Environmental Change. Prev Chronic Dis 13:E105
Montgomery, Nathan D; Parker, Joel S; Eberhard, David A et al. (2016) Identification of Human Papillomavirus Infection in Cancer Tissue by Targeted Next-generation Sequencing. Appl Immunohistochem Mol Morphol 24:490-5
Chan, Ellen S; Landay, Alan L; Brown, Todd T et al. (2016) Differential CD4+ cell count increase and CD4+ :  CD8+ ratio normalization with maraviroc compared with tenofovir. AIDS 30:2091-7
Albaugh, Daniel L; Salzwedel, Andrew; Van Den Berge, Nathalie et al. (2016) Functional Magnetic Resonance Imaging of Electrical and Optogenetic Deep Brain Stimulation at the Rat Nucleus Accumbens. Sci Rep 6:31613
Hughes, Robert M; Marvin, Christina M; Rodgers, Zachary L et al. (2016) Phototriggered Secretion of Membrane Compartmentalized Bioactive Agents. Angew Chem Int Ed Engl 55:16080-16083
Armao, Diane; Hartman, Terry; Shea, Christopher M et al. (2016) Working Face-to-Face for Pediatric CT Dose Reduction: A Community Toolkit. Diagn Imaging Eur 32:10-13

Showing the most recent 10 out of 347 publications